Direct oral anticoagulants: a guide for daily practice.

Author: BoehlenFrançoise, BounameauxHenri, FontanaPierre, RighiniMarc, Robert-EbadiHelia

Paper Details 
Original Abstract of the Article :
In recent years, small oral compounds that specifically block activated coagulation factor X (FXa) or thrombin (FIIa) have become alternatives to the anticoagulants that had been used for several decades. As of today, these direct oral anticoagulants (DOACs) include dabigatran etexilate (thrombin in...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/26964028

データ提供:米国国立医学図書館(NLM)

Direct Oral Anticoagulants: Navigating a New Era of Blood Thinners

The world of anticoagulants is a vast desert, with new discoveries constantly emerging. This study, like a well-equipped caravan exploring this terrain, delves into the realm of direct oral anticoagulants (DOACs), a new generation of blood thinners offering alternative approaches to managing venous thromboembolic disease and atrial fibrillation. While DOACs, like a refreshing oasis, represent a significant advancement in anticoagulation therapy, they also present new challenges that must be carefully addressed. The researchers, like seasoned travelers, offer practical guidelines for prescribing and managing DOACs in everyday clinical practice, drawing upon updated recommendations from reputable organizations like the European Heart Rhythm Association and the American College of Chest Physicians.

DOACs: Navigating the Complexities of Blood Thinning Therapy

The study, like a compass guiding us through the desert, provides a comprehensive overview of DOACs, addressing crucial aspects like pharmacokinetics, dosing, side effects, drug interactions, and monitoring. The researchers highlight the importance of considering individual patient characteristics, such as renal function and concomitant medications, when choosing and managing DOAC therapy.

DOACs: A Collaborative Approach to Safe and Effective Treatment

This study, like a collaborative caravan traversing a challenging desert, underscores the need for a close partnership between patients and healthcare providers. Open communication and careful monitoring are essential to ensure safe and effective DOAC therapy. This research encourages us to embrace these new advances in anticoagulation therapy while navigating the potential complexities with careful consideration and informed decision-making.

Dr.Camel's Conclusion

This study, like a well-worn trail in the desert, provides invaluable guidance for navigating the landscape of direct oral anticoagulants. The authors offer practical advice for prescribing and managing these powerful medications, ensuring safe and effective treatment for patients with venous thromboembolic disease and atrial fibrillation. As we continue to explore the vast desert of anticoagulation therapy, it's important to remember that every patient is unique, requiring a tailored approach that considers their individual needs and circumstances.

Date :
  1. Date Completed 2016-10-12
  2. Date Revised 2017-01-03
Further Info :

Pubmed ID

26964028

DOI: Digital Object Identifier

smw-14286

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.